Clinical Trials Logo

Clinical Trial Summary

In this prospective study, we tried to select the operation time according to the cyst size and evaluate the treatment effect.


Clinical Trial Description

A choledochal cyst (CDC) is a congenital anomaly of the biliary system, which is more common in the Asian population. If a CDC is not diagnosed and treated promptly, it often leads to a series of serious complications, including cholangitis, cyst rupture, cholestatic cirrhosis, and even cholangiocarcinoma. Infants with a postnatal diagnosis of CDC often present with symptoms, and to avoid the occurrence of serious complications, operative correction should be performed as soon as possible when their clinical conditions allow. However, in the current era with the improvement of prenatal screening technology, an increasing number of choledochal cysts are diagnosed prenatally in the fetus. In developed countries, as many as 15% of choledochal cysts are found before birth. Some of these children receive intervention when they are asymptomatic at an early stage, while some have progressed to CDC-related symptoms before operative correction. The timing of operation for children with a prenatal diagnosis of CDC remains controversial. The investigators previous study showed that it is more advantageous to receive surgical treatment in the asymptomatic period for patients with prenatally diagnosed CDC. In addition, the age at operation (months) appears to be unrelated to intraoperative and postoperative complications, which is distinct from previous studies. More interestingly, the investigators found that a specific cyst size (length > 5.2 cm and width > 4.1 cm) suggested that clinical symptoms might appear and that the surgery should be performed as soon as clinically safe to proceed. Therefore, in this study, the investigators tried to select the operation time according to the cyst size and evaluate the treatment effect. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05620485
Study type Interventional
Source Guangzhou Women and Children's Medical Center
Contact xisi guan
Phone 13926155230
Email 545280987@qq.com
Status Not yet recruiting
Phase N/A
Start date November 15, 2022
Completion date November 15, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06111872 - Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography. Phase 2
Recruiting NCT06418490 - The Application of Digital Intelligent Diagnostic and Therapeutic Technology in Biliary Dilation Diagnosis
Recruiting NCT02801500 - Superior Bilioenteric Anastomosis by Magnetic Compressive Technique N/A
Completed NCT04319302 - Isolated Vascularized Gastric Tube Biliary Enteric Drainage: A Paediatric Case Series Experience.
Recruiting NCT05181332 - Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis
Recruiting NCT03774589 - Bilioenteric Anastomosis by Magnetic Compressive Technique N/A